Citadel Securities urges the SEC to strengthen regulation of tokenized stocks and avoid exempting them from securities rules
According to ChainCatcher, TheBlock reports that Wall Street’s prominent market maker Citadel Securities stated in a letter to the U.S. Securities and Exchange Commission (SEC) that tokenized stocks are facing resistance.
Citadel urges the SEC to avoid exempting securities regulations and instead focus on market liquidity and investor protection. The company is concerned that tokenized assets could drain liquidity from traditional markets and notes that investors are confused about who is issuing these assets.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Bristol-Myers Squibb (BMY.US) rises in pre-market trading! Two experimental drugs report positive results in Phase 3 clinical trials, diversifying and accelerating the pipeline
Bristol Myers Squibb's two experimental drugs, used to treat a rare endocrine cancer and a deadly lung disease, have achieved success in Phase III clinical trials, injecting momentum into the pharmaceutical company’s new product pipeline.
BUZZ-Enovix shares rise on preliminary revenue growth in the third quarter
Citius Pharma CEO Mazur presents at ThinkEquity Conference
Crypto prices
More
